GFAP-deficient astrocytes are capable of stellation in vitro when cocultured with neurons and exhibit a reduced amount of intermediate filaments and an increased cell saturation density

Experimental Cell Research

Volumn 239, Issue 2, 1998, Pages 332-343

  Pekny, Milos ^a   Eliasson, Camilla ^a   Chien, Chung Liang ^b   Kindblom, Lars Gunnar ^a   Liem, Ronald ^b   Hamberger, Anders ^a   Betsholtz, Christer ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b The New York Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN;

ANIMAL CELL; ARTICLE; ASTROCYTE; COCULTURE; CONTROLLED STUDY; IMMUNOCYTOCHEMISTRY; INTERMEDIATE FILAMENT; MICROFILAMENT; MICROTUBULE; MOUSE; NERVE CELL CULTURE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALIA;

EID: 0031814670     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1997.3922     Document Type: Article

References (50)

1. Pekny M., Levéen P., Pekna M., Eliasson C., Berthold C. H., Westermark B., Betsholtz C. Mice lacking glial fibrillary acidic protein display astrocytes devoid of intermediate filaments but develop and reproduce normally. EMBO J. 14:1995;1590-1598.
2. Coulombe P. A., Hutton M. E., Letai A., Hebert A., Paller A. S., Fuchs E. Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: Genetic and functional analyses. Cell. 66:1991;1301-1311.
3. Cheng J., Syder A. J., Yu Q. C., Letai A., Paller A. S., Fuchs E. The genetic basis of epidermolytic hyperkeratosis: A disorder of differentiation-specific epidermal keratin genes. Cell. 70:1992;811-819.
4. Chipev C. C., Korge B. P., Markova N., Bale S. J., DiGiovanna J. J., Compton J. G., Steinert P. M. A leucine-proline mutation in the H1 subdomain of keratin 1 causes epidermolytic hyperkeratosis. Cell. 70:1992;821-828.
5. Epstein E. J. Molecular genetics of epidermolysis bullosa. Science. 256:1992;799-804.
6. Lane E. B., Rugg E. L., Navsaria H., Leigh I. M., Heagerty A. H., Ishida Y. A., Eady R. A. A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering. Nature. 356:1992;244-246.
7. Rothnagel J. A., Dominey A. M., Dempsey L. D., Longley M. A., Greenhalgh D. A., Gagne T. A., Huber M., Frenk E., Hohl D., Roop D. R. Mutations in the rod domains of keratins 1 and 10 in epidermolytic hyperkeratosis. Science. 257:1992;1128-1130.
8. Chan Y., Anton L. I., Yu Q. C., Jäckel A., Zabel B., Ernst J. P., Fuchs E. A human keratin 14 "knockout": The absence of K14 leads to severe epidermolysis bullosa simplex and a function for an intermediate filament protein. Genes Dev. 8:1994;2574-2587.
9. Rugg E. L., Morley S. M., Smith F. J., Boxer M., Tidman M. J., Navsaria H., Leigh I. M., Lane E. B. Missing links: Weber-Cockayne keratin mutations implicate the L12 linker domain in effective cytoskeleton function. Nat. Genet. 5:1993;294-300.
10. Kremer H., Zeeuwen P., McLean W. H., Mariman E. C., Lane E. B., van de Kerkhof C., Ropers H. H., Steijlen P. M. Ichthyosis bullosa of Siemens is caused by mutations in the keratin 2e gene. J. Invest. Dermatol. 103:1994;286-289.
11. Baribault H., Price J., Miyai K., Oshima R. G. Mid-gestational lethality in mice lacking keratin 8. Genes Dev. 7:1993;1191-1202.
12. Baribault H., Penner J., Iozzo R. V., Wilson H. M. Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. Genes Dev. 8:1994;2964-2973.
13. Ohara O., Gahara Y., Miyake T., Teraoka H., Kitamura T. Neurofilament deficiency in quail caused by nonsense mutation in neurofilament-L gene. J. Cell Biol. 121:1993;387-395.
14. Eyer J., Peterson A. Neurofilament-deficient axons and perikaryal aggregates in viable transgenic mice expressing a neurofilament-beta-galactosidase fusion protein. Neuron. 12:1994;389-405.
15. Côté F., Collard J. F., Julien J. P. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: A mouse model of amyotrophic lateral sclerosis. Cell. 73:1993;35-46.
16. Xu Z., Cork L. C., Griffin J. W., Cleveland D. W. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell. 73:1993;23-33.
17. Collard J. F., Côté F., Julien J. P. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature. 375:1995;61-64.
18. Colucci-Guyon E., Portier M. M., Dunia I., Paulin D., Pournin S., Babinet C. Mice lacking vimentin develop and reproduce without an obvious phenotype. Cell. 79:1994;679-694.
19. Gomi H., Yokoyama T., Fujimoto K., Ikeda T., Katoh A., Itoh T., Itohara S. Mice devoid of the glial fibrillary acidic protein develop normally and are susceptible to scrapie prions. Neuron. 14:1995;29-41.
20. Shibuki K., Gomi H., Chen L., Bao S., Kim J. J., Wakatsuki H., Fujisaki K., Fujimoto K., Katoh A., Ikeda T., Chen C., Thompson R. F., Itohara S. Deficient cerebellar long-term depression, impared eyeblink conditioning, and normal motor coordination in GFAP mutant mice. Neuron. 16:1996;587-599.
21. McCall M. A., Gregg R. G., Behringer R. R., Brenner M., Delaney C. L., Galbreath E. J., Zhang C. I., Pearce R. A., Chiu S. Y., Messing A. Targeted deletion in astrocyte intermediate filament (Gfap) alters neuronal physiology. Proc. Natl. Acad. Sci. USA. 93:1996;6361-6366.
22. Liedtke W., Edelmann W., Bieri P. L., Chiu F.-C., Cowan N. J., Kucherlapati R., Raine C. S. GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron. 17:1996;607-615.
23. Eng L. F., Ghirnikar R. S. GFAP and astrogliosis. Brain Pathol. 4:1994;229-237.
24. Goebel H. H., Schlie M., Eng L. F. Immunohistopathologic spectrum of the glial fibrillary acidic protein in neurooncology. Acta Histochem. Suppl. 34:1987;81-93.
25. van der Meulen D. J., Houthoff H. J., Ebels E. J. Glial fibrillary acidic protein in human gliomas. Neuropathol. Appl. Neurobiol. 4:1978;177-190.
26. Jacque C. M., Vinner C., Kujas M., Raoul M., Racadot J., Baumann N. A. Determination of glial fibrillary acidic protein (GFAP) in human brain tumors. J. Neurol. Sci. 35:1978;147-155.
27. Velasco M. E., Dahl D., Roessmann U., Gambetti P. Immunohistochemical localization of glial fibrillary acidic protein in human glial neoplasms. Cancer. 45:1980;484-494.
28. Tascos N. A., Parr J., Gonatas N. K. Immunocytochemical study of the glial fibrillary acidic protein in human neoplasms of the central nervous system. Hum. Pathol. 13:1982;454-458.
29. Hara A., Sakai N., Yamada H., Niikawa S., Ohno T., Tanaka T., Mori H. Proliferative assessment of GFAP-positive and GFAP-negative glioma cells by nucleolar organizer region staining. Surg. Neurol. 36:1991;190-194.
30. Kajiwara K., Orita T., Nishizaki T., Kamiryo T., Nakayama H., Ito H. Glial fibrillary acidic protein (GFAP) expression and nucleolar organizer regions (NORs) in human gliomas. Brain Res. 572:1992;314-318.
31. Rutka J. T., Smith S. L. Transfection of human astrocytoma cells with glial fibrillary acidic protein complementary DNA: Analysis of expression, proliferation, and tumorigenicity. Cancer Res. 53:1993;3624-3631.
32. Toda M., Miura M., Asou H., Toya S., Uyemura K. Cell growth suppression of astrocytoma C6 cells by glial fibrillary acidic protein cDNA transfection. J. Neurochem. 63:1994;1975-1978.
33. Rutka J. T., Hubbard S. L., Fukuyama K., Matsuzawa K., Dirks P. B., Becker L. E. Effects of antisense glial fibrillary acidic protein complementary DNA on the growth, invasion, and adhesion of human astrocytoma cells. Cancer Res. 54:1994;3267-3272.
34. Weinstein D. E., Shelanski M. L., Liem R. K. Suppression by antisense mRNA demonstrates a requirement for the glial fibrillary acidic protein in the formation of stable astrocytic processes in response to neurons. J. Cell Biol. 112:1991;1205-1213.
35. Chen W. J., Liem R. K. Reexpression of glial fibrillary acidic protein rescues the ability of astrocytoma cells to form processes in response to neurons. J. Cell Biol. 127:1994;813-823.
36. Hansson E., Rönnbäck L. Primary cultures of astroglia and neurons from different brain regions. A Dissection and Tissue Culture Manual of the Nervous System. 1989;A. R. Liss, New York. p. 92-104.
37. Ciotti M. T., Mercenti D., Levi G. Rapid staining method for cultured astrocytes. Shahar A., de Vellis J., Vernadakis A., Haber B. A Dissection and Tissue Culture Manual of the Nervous System. 1989;291-292 A. R. Liss, New York.
38. Gasser U. E., Hatten M. E. Neuron-glia interactions of rat hippocampal cells in vitro: Glial-guided neuronal migration and neuronal regulation of glial differentiation. J. Neurosci. 10:1990;1276-1285.
39. Dahlstrand J., Collins V. P., Lendahl U. Expression of the class VI intermediate filament nestin in human central nervous system tumors. Cancer Res. 52:1992;5334-5341.
40. Kaplan M. P., Chin S. S., Macioce P., Srinawasan J., Hashim G., Liem R. K. Characterization of a panel of neurofilament antibodies recognizing N-terminal epitopes. J. Neurosci. Res. 30:1991;545-554.
41. Kaplan M., Chin S. S., Fliegner K. H., Liem R. K. Alpha-internexin, a novel neuronal intermediate filament protein, precedes the low molecular weight neurofilament protein (NF-L) in the developing rat brain. J. Neurosci. 10:1990;2735-2748.
42. Ching G. Y., Liem R. K. Assembly of type IV neuronal intermediate filaments in nonneuronal cells in the absence of preexisting cytoplasmic intermediate filaments. J. Cell Biol. 122:1993;1323-1335.
43. Lowry O. H., Rosebrough N. I., Farr A. L., Randall R. I. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
44. Widéhn S., Kindblom L. G. Agarose embedding: A new method for the ultrastructural examination of the in-situ morphology of cell cultures. Ultrastruct. Pathol. 14:1990;81-85.
45. Hatten M. E. Neuronal regulation of astroglial morphology and proliferation in vitro. J. Cell Biol. 100:1985;384-396.
46. Cammer W., Tansey F., Abramovitz M., Ishigaki S., Listowski I. Differential localization of glutathione-S-transferase YP and YB subunits in oligodentrocytes and astrocytes of rat brain. J. Neurochem. 52:1989;876-883.
47. Meyer S. A., Ingraham C. A., McCarthy K. D. Expression of vimentin by cultured astroglia and oligodendroglia. J. Neurosci. Res. 24:1989;251-259.
48. Frisén J., Johansson C. B., Török C., Risling M., Lendahl U. Rapid, widespread and longlasting induction of nestin contributes to the generation of glial scar tissue after CNS injury. J. Cell Biol. 131:1995;453-464.
49. Herpers M. J., Ramaekers F. C., Aldeweireldt J., Moesker O., Slooff J. Co-expression of glial fibrillary acidic protein- and vimentin-type intermediate filaments in human astrocytomas. Acta Neuropathol. 70:1986;333-339.
50. Escalone Z. J. Astrocytes in brain tumours. Differentiation or trapping? Histol. Histopathol. 9:1994;325-332.